DNA methylation profiling of urological cancers identifies novel cancer-specific and pan-cancer biomarkers, and reveals differentially activated pathways for therapeutic targeting
Por:
Lobo, J, Constâncio, V, Gomez, A, Ramalho-Carvalho, J, Carneiro, I, Freitas, R, Esteller, M, Henrique, R and Jerónimo, C
Publicada:
1 sep 2025
Resumen:
Filiaciones:
Lobo, J:
Portuguese Oncol Inst Porto IPO Porto, Pathol, Porto, Portugal
Constâncio, V:
Portuguese Oncol Inst Porto IPO Porto, Canc Biol & Epigenet Grp, Porto, Portugal
Gomez, A:
Univ Vic Cent Univ Catalonia UVic UCC, Biosci, Barcelona, Spain
Ramalho-Carvalho, J:
Portuguese Oncol Inst Porto IPO Porto, Canc Biol & Epigenet Grp, Porto, Portugal
Carneiro, I:
Portuguese Oncol Inst Porto IPO Porto, Pathol, Porto, Portugal
Freitas, R:
Portuguese Oncol Inst Porto IPO Porto, Urol, Porto, Portugal
:
Josep Carreras Leukemia Res Inst IJC, Canc Epigenet Grp, Barcelona, Spain
Henrique, R:
Portuguese Oncol Inst Porto IPO Porto, Pathol, Porto, Portugal
Jerónimo, C:
Portuguese Oncol Inst Porto IPO Porto, Canc Biol & Epigenet Grp, Porto, Portugal
|